Same sections for every candidate. Every fact linked to its source.How we stay neutral →
Utah asks insulin users to share pricing experiences to support drug-price lawsuit
The Division of Consumer Protection wants accounts from Utah diabetes patients and caregivers covering the past 10 years. The state alleges drugmakers and pharmacy benefit managers inflated insulin prices.
AI-generated illustration: The Utah Ledger · Original graphic · The Utah Ledger
What the state is asking
Utah is asking current and former diabetes patients and their caregivers to share their experiences with insulin pricing over the past 10 years to help its lawsuit over drug prices. [1]
The Utah Division of Consumer Protection is suing major insulin manufacturers and pharmacy benefit managers, the Utah Department of Commerce said in a Nov. 10 notice seeking the accounts. [1]
Submissions go through a form at commerce.utah.gov/dcp/insulin. The department said they will be treated as official complaints and reviewed by investigators working on the lawsuit, and that people who were harmed may eventually be eligible for compensation. [1][2]
What the lawsuit alleges
The division, represented by the Utah Attorney General's Office, alleges that drug manufacturers raised wholesale insulin prices to pay larger rebates to pharmacy benefit managers, the companies that manage drug coverage for health plans. [1]
The state also alleges that pharmacy benefit managers favored high-rebate, high-cost drugs over cheaper options on health plan drug lists, and that Utah residents paid higher out-of-pocket costs as a result, because those costs were based on inflated list prices instead of actual market prices. [1]
Why the state says it matters
About 200,000 Utahns live with diabetes, according to the department, and they spend $1.7 billion on care, or one in four health care dollars spent in the state. [1]
"Your experience is vital to the state's case and our potential to recover damages as we work to ensure these companies are held to account," Dan Larsen, director of the Division of Consumer Protection, said in the release. [1]
The department said the case is part of an effort to reform the pharmaceutical supply chain and make drug pricing fair and transparent for Utah families. More information about the lawsuit is posted with the submission form. [1][2]
